These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5494524)

  • 1. [Considerations on the use of ajmaline in Wolff-Parkinson-White syndrome].
    Nicita-Mauro V
    Boll Soc Ital Cardiol; 1970; 15(2):123-32. PubMed ID: 5494524
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of ajmaline on the Wolff-Parkinson-White syndrome].
    Masior J; Platek D; Zgórniak M
    Kardiol Pol; 1965; 8(2):185-7. PubMed ID: 5836662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of ajmaline by venous route and of procaine amide in the treatment of Wolff-Parkinson-White syndrome].
    Tronconi L
    Minerva Cardioangiol; 1966 Apr; 14(4):228-31. PubMed ID: 5934148
    [No Abstract]   [Full Text] [Related]  

  • 4. [Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infants. (Apropos of a case)].
    Guerricchio G
    Minerva Cardioangiol; 1972 Jan; 20(1):27-32. PubMed ID: 5060005
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic and therapeutic significance of ajmaline in the Wolff-Parkinson-White syndrome].
    Gibert-Queraltó J; Soler-Soler J; Fort de Ribot R
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():231-5. PubMed ID: 5380595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of a complete left bundle-branch block in the WPW syndrome following Ajmaline injection].
    Speckert H; Klepzig H
    Z Kreislaufforsch; 1967 May; 56(5):490-5. PubMed ID: 5586389
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Wolff-Parkinson-White syndrome. Contribution to the therapeutic study].
    Timio M
    Minerva Cardioangiol; 1967 Dec; 15(12):866-71. PubMed ID: 5610490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Di-mono-chloroacetyl-ajmaline in the treatment of disorders of cardiac rhythm].
    Bucur V; Enescu R; Sirbulescu R; Pompilian P
    Med Interna (Bucur); 1969 Jan; 21(1):47-58. PubMed ID: 5779664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral action of N-propyl-ajmaline bitartrate. I. Preliminary note].
    Martínez-Muñoz A
    Rev Esp Cardiol; 1970 Jun; 23(2):331-40. PubMed ID: 5518738
    [No Abstract]   [Full Text] [Related]  

  • 11. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of ajmaline in the clinical diagnosis of Wolff-Parkinson-White syndrome].
    Correale E; Corsini G
    Rass Int Clin Ter; 1970 Aug; 50(16):989-1006. PubMed ID: 5469898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ajmalin in the treatment of pseudoventricular and ventricular tachycardias].
    Berkmen R; Işik K; Behar M; Oztürk A
    Turk Tip Cemiy Mecm; 1969; 35(3):170-82. PubMed ID: 5800841
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of ajmaline in the Wolff-Parkinson-White syndrome. Diagnostic value].
    Soler Soler J; Casellas Bernat A; Trilla Sánchez E
    Arch Inst Cardiol Mex; 1966; 36(1):68-73. PubMed ID: 5931302
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Ritmos on Wolff-Parkinson-White syndrome.
    Apostolov L; Batalov Z
    Folia Med (Plovdiv); 1965; 7(2):141-51. PubMed ID: 4955367
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of ajmaline in the diagnosis of the Wolff-Oarkinson-White syndrome].
    Anfossi F; Guarraggi A; Rossi PL
    Minerva Cardioangiol; 1967 Jun; 15(6):408-13. PubMed ID: 6056086
    [No Abstract]   [Full Text] [Related]  

  • 17. [On a new pharmacologic test in the Wolff-Parkinson-White syndrome].
    Apostolov L
    Minerva Med; 1967 Jan; 58(8):216-30. PubMed ID: 6020273
    [No Abstract]   [Full Text] [Related]  

  • 18. [17,21-di-monochloroacetyl-ajmaline in the prevention and therapy of cardiac arrhythmias].
    Zoli I; Baroncini S; Cornia G; Donato S; Pigini G; Melchionda N; Parenti M; Pretolani E
    Minerva Cardioangiol; 1971 Oct; 19(10):536-60. PubMed ID: 5098893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenetic considerations on the Wolff-Parkinson-White syndrome. Apropos of a case].
    Grasso A; Artese D; Ferro-Luzzi M; Belsanti V
    Sicil Sanit; 1967 Dec; 20(12):Suppl:229-46. PubMed ID: 5612410
    [No Abstract]   [Full Text] [Related]  

  • 20. [The diagnosis of combined heart conduction disorders with ajmaline].
    Homola D; Srnova V
    Z Kreislaufforsch; 1969 Jan; 58(1):89-96. PubMed ID: 5791453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.